Skip to main content

Advertisement

Table 7 Mean change in reflected wave amplitude (mmHg) after EMPA therapy separated according to median of different variables

From: How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Variable Age HbA1c Copeptin Heart rate LDL-cholesterol Uric acid Systolic BP hsCRP
≥ median − 1.82 ± 4.93 − 2.25 ± 5.05 − 2.56 ± 4.54 − 0.88 ± 4.74 − 0.43 ± 5.86 − 1.94 ± 4.45 − 1.44 ± 5.18 − 0.26 ± 4.54
< median − 0.83 ± 4.64 − 0.41 ± 4.36 − 0.35 ± 4.78 − 1.82 ± 4.84 − 2.11 ± 3.49 − 0.79 ± 5.03 − 1.24 ± 4.46 − 2.39 ± 4.83
p-value 0.449 0.159 0.091 0.471 0.199 0.382 0.877 0.101
  1. Data are given as mean ± SD
  2. hsCRP high sensitive C-reactive protein, LDL-cholesterol low density lipid cholesterol, heart rate 24-h ambulatory heart rate, systolic BP systolic 24-h ambulatory blood pressure